A SARS-CoV-2 spike-targeting bispecific T-cell engager strategy for controlling SARS-CoV-2 infection

Researchers described a novel strategy for controlling severe acute respiratory syndrome coronavirus 2.

Related Keywords

Tsuguliev Shutterstock ,Communications Biology Journal ,Cell ,Cars ,Ars Cov 2 ,T Cell ,Ngiotensin ,Antibodies ,Ntibody ,Coronavirus ,Covid 19 ,Cytotoxicity ,Efficacy ,Nzyme ,N Vivo ,Embrane ,Mesenchymal Stem Cells ,Ortality ,Pandemic ,Protein ,Eceptor ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Small Molecules ,Spike Protein ,Stem Cells ,Yndrome ,Technology ,Virus ,